GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (NAS:FBLG) » Definitions » Additional Paid-In Capital

FibroBiologics (FibroBiologics) Additional Paid-In Capital : $28.95 Mil(As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics Additional Paid-In Capital?


FibroBiologics's quarterly additional paid-in capital increased from Sep. 2023 ($25.18 Mil) to Dec. 2023 ($25.61 Mil) and increased from Dec. 2023 ($25.61 Mil) to Mar. 2024 ($28.95 Mil).

FibroBiologics's annual additional paid-in capital increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($2.41 Mil) and increased from Dec. 2022 ($2.41 Mil) to Dec. 2023 ($25.61 Mil).


FibroBiologics Additional Paid-In Capital Historical Data

The historical data trend for FibroBiologics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics Additional Paid-In Capital Chart

FibroBiologics Annual Data
Trend Dec21 Dec22 Dec23
Additional Paid-In Capital
- 2.41 25.61

FibroBiologics Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only - 23.80 25.18 25.61 28.95

FibroBiologics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

FibroBiologics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of FibroBiologics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


FibroBiologics (FibroBiologics) Business Description

Comparable Companies
Traded in Other Exchanges
Address
455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598
FibroBiologics Inc is an early-stage, cell therapy company. Its primary focus is the initiation and progression of preclinical studies and clinical-stage FDA trials related to fibroblast treatments for Degenerative Disc Disease, Multiple Sclerosis, Cancer, Wound Healing, and other diseases.

FibroBiologics (FibroBiologics) Headlines